News

 

Ridge Pharma launch dedicated Oxypro® prolonged release website

14th March 2019

We have just launched a dedicated website for our product Oxypro prolonged release tablets (oxycodone hydrochloride). The website features a wealth of useful information for both patients and healthcare professionals. Check out the website at www.oxypro-info.com.

 

Ridge Pharma to attend Europlx - Partnering Conference

25th – 26th February 2019 | London Heathrow

Ridge Pharma are excited to announce that we will be attending Euro PLX at London Heathrow on the 25th-26th of February 2019. If you would like to schedule a meeting, please contact us. More information on Euro PLX can be found here.

 

Ridge Pharma launches Oxypro® prolonged release tablets (oxycodone hydrochloride)

9th Nov 2018

Ridge Pharma are pleased to announce the launch of Oxypro® prolonged release tablets (oxycodone hydrochloride). For further information healthcare professionals should contact info@ridge-pharma.com or call 0118 214 1220.

 

Ridge Pharma secures £3.2m investment led by NVM

17th Sept 2018

NVM Private Equity (NVM) has invested £2.75 million into Ridge Pharma. This funding will aid commercialisation of our first product in late 2018, with further launches thereafter. Read more . . .